Siderowf A - Search Results

1

Neurofilament Light Chain as a Biomarker for Cognitive Decline in Parkinson Disease.

Aamodt WW, Waligorska T, Shen J, Tropea TF, Siderowf A, Weintraub D, Grossman M, Irwin D, Wolk DA, Xie SX, Trojanowski JQ, Shaw LM, Chen-Plotkin AS. Aamodt WW, et al. Among authors: siderowf a. Mov Disord. 2021 Dec;36(12):2945-2950. doi: 10.1002/mds.28779. Epub 2021 Sep 4. Mov Disord. 2021. PMID: 34480363 Free PMC article.

2

Cost-effectiveness analysis in Parkinson's disease: determining the value of interventions.

Siderowf AD, Holloway RG, Stern MB. Siderowf AD, et al. Mov Disord. 2000 May;15(3):439-45. doi: 10.1002/1531-8257(200005)15:3<439::AID-MDS1004>3.0.CO;2-F. Mov Disord. 2000. PMID: 10830407 Review. No abstract available.

3

Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial.

Siderowf A, McDermott M, Kieburtz K, Blindauer K, Plumb S, Shoulson I; Parkinson Study Group. Siderowf A, et al. Mov Disord. 2002 Jul;17(4):758-63. doi: 10.1002/mds.10011. Mov Disord. 2002. PMID: 12210871 Clinical Trial.

4

Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease.

Lynch DR, Mozley PD, Sokol S, Maas NM, Balcer LJ, Siderowf AD. Lynch DR, et al. Mov Disord. 2003 Jul;18(7):804-12. doi: 10.1002/mds.10430. Mov Disord. 2003. PMID: 12815660

5

Development of quality of care indicators for Parkinson's disease.

Cheng EM, Siderowf A, Swarztrauber K, Eisa M, Lee M, Vickrey BG. Cheng EM, et al. Among authors: siderowf a. Mov Disord. 2004 Feb;19(2):136-50. doi: 10.1002/mds.10664. Mov Disord. 2004. PMID: 14978668 Review.

6

Multiple pathologies in a patient with a progressive neurodegenerative syndrome.

Liang TW, Forman MS, Duda JE, McCluskey L, Trojanowski JQ, Siderowf A. Liang TW, et al. Among authors: siderowf a. J Neurol Neurosurg Psychiatry. 2005 Feb;76(2):252-5. doi: 10.1136/jnnp.2004.039479. J Neurol Neurosurg Psychiatry. 2005. PMID: 15654043 Free PMC article.

7

Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.

Weintraub D, Newberg AB, Cary MS, Siderowf AD, Moberg PJ, Kleiner-Fisman G, Duda JE, Stern MB, Mozley D, Katz IR. Weintraub D, et al. J Nucl Med. 2005 Feb;46(2):227-32. J Nucl Med. 2005. PMID: 15695780 Free article. Clinical Trial.

8

[99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease.

Siderowf A, Newberg A, Chou KL, Lloyd M, Colcher A, Hurtig HI, Stern MB, Doty RL, Mozley PD, Wintering N, Duda JE, Weintraub D, Moberg PJ. Siderowf A, et al. Neurology. 2005 May 24;64(10):1716-20. doi: 10.1212/01.WNL.0000161874.52302.5D. Neurology. 2005. PMID: 15911797

9

Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson's disease.

Siderowf A, Jaggi JL, Xie SX, Loveland-Jones C, Leng L, Hurtig H, Colcher A, Stern M, Chou KL, Liang G, Maccarone H, Simuni T, Baltuch G. Siderowf A, et al. Mov Disord. 2006 Jun;21(6):746-53. doi: 10.1002/mds.20786. Mov Disord. 2006. PMID: 16463342 Clinical Trial.

10

Preclinical diagnosis of Parkinson's disease: are we there yet?

Siderowf A, Stern MB. Siderowf A, et al. Curr Neurol Neurosci Rep. 2006 Jul;6(4):295-301. doi: 10.1007/s11910-006-0021-z. Curr Neurol Neurosci Rep. 2006. PMID: 16822349 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters